Wells Fargo & Company Pulse Biosciences, Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLSE
# of Institutions
60Shares Held
4.78MCall Options Held
138KPut Options Held
96.2K-
Black Rock Inc. New York, NY1.15MShares$21.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA905KShares$17 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC783KShares$14.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA424KShares$7.97 Million0.0% of portfolio
-
State Street Corp Boston, MA392KShares$7.36 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $698M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...